The global cancer tissue diagnostics report places a strong emphasis on understanding the future forecast, growth opportunities, key markets as well as players. The World Health Organization (WHO) has released data that has revealed that 9.6 million people were affected by cancer mortality around the world in 2018. Demand on the global cancer diagnostics market is increasing due to more cancer incidences. In addition to the above, the demand for cancer tissue diagnostics is going up due to increasing awareness as well as initiatives by the government for research and development in oncology, devices, and treatments.
Significant advances in cancer study, as well as diagnosis technology, have been made due to the development of broader as well as more precise methods such as hybridization, transcriptomics, NGS (next-generation sequencing), ARMS (amplification-refractory mutation system, proteomics, genomics, and so on. In fact, the spread of cancer has been proved to be reduced due to screening tests. This has resulted in the cancer diagnostics market growing quickly as well as generative huge revenue. In 2018, the global cancer diagnostics market was valued at $135 billion. Most of this was attributed to innovative cancer detection devices and therapeutic development.
Breast cancer is the second leading cause of death among women. In order to detect and diagnose abnormal cell growth in the breast region, effective screening tests are required. Biopsy, mammogram, and ultrasounds are procedures that are used around the world for breast cancer diagnosis. The segment is projected to grow at a CAGR of 28% all the way to 2025. The American Cancer Society has released figures that estimate that they will see 1,762,450 new cancer incidences in the United States in 2018.
- Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.
Bio Rad Laboratories Inc.
Enzo Life Sciences, Inc.
Agilent Technologies, Inc.
Cancer Genetics Inc.
Merck KGaA (Sigma-Aldrich Co. LLC)
The global cancer tissue diagnostics market is segmented by type, application, and region. On the basis of type, the market is split into immunohistochemistry (IHC) test and in situ hybridization test. On the basis of application, the market is split into hospitals, clinics, and others. On the basis of region, the market is split into North America, Europe, China, Japan, Southeast Asia, India, and Central & South America
North America is leading the market demand for cancer tissue diagnostics. It held the lion’s share of the regional share at 37% in 2018. The demand for cancer tissue diagnostics is expected to rise at a CAGR of 6.2% during the forecast period 2019-2025. This is because cancer diagnosis is still an integral part of the modern oncology segment. The treatment reduces costs by cutting away additional treatment costs that would have announced their presence in the advanced stages of cancer.
Latest industry news
The growing prevalence of cancer along with higher demand for personalized medicine is expected to push the growth of the tissue diagnostic market forward for the forecast period. In addition to the above, the global geriatric population base is rising, the demand for cost-effective and safe treatment is increasing and expenditure in the healthcare sector is increasing. All of this is pushing the cancer tissue diagnostics market forward.
Table Of Content:
1 Market Overview
2 Global Market Competition by Manufacturers
3 Global Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Production, Revenue (Value), Price Trend by Type
6 Global Market Analysis by Application
7 Global Manufacturers Profiles/Analysis
8 Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Market Forecast (2018-2025)
13 Research Findings and Conclusion
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349